Search Results - "De Boer, Jantine Posthuma"

The Clay Shoveler's Fracture: A Case Report and Review of the Literature by Posthuma de Boer, Jantine, MD, PhD, van Wulfften Palthe, Alexander F.Y., MD, Stadhouder, Agnita, MD, Bloemers, Frank W., MD, PhD

“…Abstract Background A clay-shoveler's fracture is a very rarely occurring stress-type avulsion fracture of the lower cervical or upper thoracic spinous…”
Get full text

EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment by Haghiralsadat, Fateme, Amoabediny, Ghasem, Naderinezhad, Samira, Nazmi, Kamran, De Boer, Jantine Posthuma, Zandieh-Doulabi, Behrouz, Forouzanfar, Tymour, Helder, Marco N.

“…ABSTRACT Purpose To employ Doxorubicin-loaded liposomes, modified with YSA-peptide to target EphA2, to reduce adverse effects against primary bone cells and…”
Get full text

Targeting JNK-interacting-protein-1 (JIP1) sensitises osteosarcoma to doxorubicin by Posthumadeboer, Jantine, van Egmond, Pim W, Helder, Marco N, de Menezes, Renée X, Cleton-Jansen, Anne-Marie, Beliën, Jeroen A M, Verheul, Henk M W, van Royen, Barend J, Kaspers, Gert-Jan J L, van Beusechem, Victor W

“…Osteosarcoma (OS) is the most common primary malignant bone tumour in children and adolescents. Despite aggressive therapy, survival outcomes remain…”
Get full text

Long-term clinical outcome of collagenase clostridium histolyticum treatment is independent of Dupuytren Diathesis Score by VAN NUFFEL, Maarten, POSTHUMA DE BOER, Jantine, COOTJANS, Katrien, BORGERS, Anton, DE SMET, Luc, DEGREEF, Ilse

“…Collagenase clostridium histolyticum (CCH) is a pharmaceutical, non-surgical treatment option for Dupuytren Disease. However, recurrence is common, and…”
Get full text